Regulatory Compliance

Olympus Boosts MedTech Reach with $150M Fund II Aligned to Endoscopy Growth

Olympus has launched a second medtech corporate venture fund (OIV ...

The fund targets early- to growth-stage startups globally in GI, u...

Olympus will pair capital with clinical, technical, regulatory, an...

The strategy spreads risk through deal sizes of up to about $10m w...

Paladin Power Moves Toward IPO with Aegis Capital: Key Financial & Risk Insights

Paladin Power, a U.S. veteran-owned energy storage startup, has en...

The company offers fully integrated, behind-the-meter power system...

Paladin’s financials show small but growing contracted revenue, ...

While macro tailwinds for resilient energy storage are strong, Pal...

Netflix-Warner Bros. Deal: Why Antitrust, Politics & Big Financial Risks Could Stall It

Netflix is proposing a $72 billion acquisition of Warner Bros. Dis...

The company argues it needs Warner Bros to compete with YouTube’...

The deal faces heavy regulatory and political opposition over conc...

Netflix would take on about $59 billion in new debt amid a rival, ...

Macquarie Group’s Corporate Risks: Governance Strains Behind Mixed Financials

There is no credible evidence of specific internal "ructions" in M...

Macquarie faces mounting governance pressure, including a sharehol...

Group profit is growing modestly, with strong contributions from A...

Key uncertainties centre on leadership accountability, potential b...
Scroll to Top